Desq Long
Sign in
SEC FORM 4
$23,940.00

Oruka Therapeutics, Inc. (ORKA)

Acquisition (code M) of 3,500 shares at $6.84 per share.

Reporting Person Goncalves Joana · Officer Title Chief Medical Officer · Transaction Code M

Traded Aug 17, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0000907654-26-000079 · filed 2026-08-17 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Oruka Therapeutics, Inc. (ORKA)." Disclosed 2026-08-17. https://desqlong.com/cards/0000907654-26-000079-1 (retrieved 2026-09-26).